Tag: Genfit
Unusual volumes on the stock market today: PCAS, Genfit
During this stock market session on Friday September 8, 2023, particularly high trading volumes were detected on the French market. Today, it is the PCAS share which stands out, with…
Genfit: well oriented after analyst comments
(CercleFinance.com) – Genfit climbs by more than 7% on the back of favorable comments from Oddo BHF which reaffirms its ‘outperformance’ opinion and raises its price target from 8.8 to…
Unusual volumes on the stock market today: Genfit, Chargeurs
During this stock market session on Thursday September 7, 2023, particularly high trading volumes were detected on the French market. Today, it is the Genfit stock that stands out, with…
Genfit: positive data for a NASH test
(CercleFinance.com) – Genfit announces the publication of new data showing that the clinical performance of its NIS2+ was superior to other tests for the diagnosis of high-risk non-alcoholic steatohepatitis (NASH)…
Genfit: publication of new data on the clinical performance of NIS2+
(AOF) – Genfit, a late-stage biopharmaceutical company committed to improving the lives of patients with rare and serious liver diseases, announces the publication of new data on the clinical performance…
Genfit: Tang Capital Partners holds less than 5% of the capital
(CercleFinance.com) – Tang Capital Partners declared that on July 6, 2023, it crossed the threshold of 5% of the capital of Genfit and held 2,450,404 Genfit shares representing as many…
Unusual volumes on the stock market today: Genfit, Casino Guichard
During this trading session on Friday June 30, 2023, particularly high trading volumes were detected on the French market. Today, it is the Genfit share that stands out, with trading…
Unusual volumes on the stock market today: Genfit
During this trading session on Thursday June 22, 2023, particularly high trading volumes were detected on the French market. Today, it is the Genfit share that stands out, with trading…
Genfit Announces New Data at the 2023 European Association for the Study of the Liver (EASL) Congress
By Claude Leguilloux Published on 06/08/2023 at 07:38 (Boursier.com) — GENFIT a late-stage biopharmaceutical company committed to…
Genfit: the resolutions recommended by the Board of Directors have been approved
AS Published on 05/24/2023 at 8:04 p.m. (Boursier.com) — The biopharmaceutical company Genfit held its…
Genfit: Publication of an article on NIS2+ technology
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Genfit: cash of 140.2 million euros, visibility until the 3rd quarter of 2024 – 04/14/2023 at 09:46
(AOF) – Genfit announces that its cash amounted to 140.2 million euros as of December 31, 2022, a level “capable of financing operations until the third quarter of 2024”. This…